Comments from Speaker
Artificial Intelligence (AI) is expected to be a promising tool even for drug development.
Although this technical field is an unknown area for people in the field of life sciences, it has become inevitable.
Herein, I would like to simply explain AI × Pharmaceutical Patents in Japan from the viewpoint of life sciences.
- What is AI?
- Examination Guidelines for AI-related patents in Japan
- Examples of AI × Pharmaceutical Patents in Japan
Note
- The webinar is expected to consist of a 20 to 30-minute presentation and a 5 to 10-minute Q&A session.
- If you miss watching the live session, you will receive an on-demand recorded video link a day after the live session is over. Please still register with the above link.
- This webinar is aimed at providing IP information to our business partners and clients from overseas. Registration from persons who work for IP firms or law firms in Japan will not be approved as this may be deemed as a conflict of interest with our business.